Stone and Laser Therapies Post-Market Study (SALT)
Recruiting
Observational Study
Benign Prostate Hypertrophy(BPH)
Renal Calculi
Ureteral Stones, Kidney Stones
Calculi, Urinary
Urinary Tract Procedure
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Any
- Study type
- Observational
- Participants needed
- 238 (estimated)
- Sponsor
- Boston Scientific Corporation · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The objective of the SALT Study is to obtain post-market safety and device performance data for Boston Scientific's Stone and BPH study devices used during a diagnostic and/or therapeutic urinary tract procedure (e.g., transurethral or percutaneous access routes) or benign prostatic hyperplasia (BPH) treatment.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
For urinary tract procedure cohort:
1. Subject intends to undergo diagnostic and/or therapeutic urinary tract procedure with qualified BSC device(s)
2. Subject is willing and able to complete all follow-up visits
For BPH cohort:
1. Subject is ≥ 40 years of age
2. Subject with…
Contacts
Curtis Blackwell
952-930-6000
CONTACT